Quantum-Si (NASDAQ:QSI) Earns “Buy” Rating from HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price target suggests a potential upside of 118.58% from the company’s previous close.

Quantum-Si Stock Performance

NASDAQ:QSI opened at $1.83 on Friday. The stock has a 50-day simple moving average of $1.79 and a two-hundred day simple moving average of $1.68. The firm has a market capitalization of $259.44 million, a PE ratio of -2.69 and a beta of 3.04. Quantum-Si has a 52-week low of $1.12 and a 52-week high of $3.90.

Quantum-Si (NASDAQ:QSI) last issued its earnings results on Thursday, February 29th. The company reported ($0.16) earnings per share for the quarter, hitting the consensus estimate of ($0.16). The company had revenue of $0.40 million during the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative net margin of 8,868.76% and a negative return on equity of 30.65%. Equities analysts forecast that Quantum-Si will post -0.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Quantum-Si

In other news, CFO Jeffry R. Keyes bought 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were bought at an average cost of $1.61 per share, for a total transaction of $80,500.00. Following the completion of the transaction, the chief financial officer now owns 50,000 shares of the company’s stock, valued at $80,500. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Jeffry R. Keyes acquired 50,000 shares of Quantum-Si stock in a transaction on Tuesday, March 5th. The shares were acquired at an average price of $1.61 per share, with a total value of $80,500.00. Following the purchase, the chief financial officer now directly owns 50,000 shares in the company, valued at approximately $80,500. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jeffrey Alan Hawkins acquired 25,000 shares of the firm’s stock in a transaction dated Thursday, March 14th. The shares were purchased at an average cost of $1.76 per share, for a total transaction of $44,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 25,000 shares in the company, valued at $44,000. The disclosure for this purchase can be found here. Insiders purchased 85,000 shares of company stock valued at $141,900 in the last 90 days. Insiders own 30.04% of the company’s stock.

Institutional Trading of Quantum-Si

Large investors have recently made changes to their positions in the business. Simplicity Wealth LLC purchased a new stake in Quantum-Si during the 1st quarter valued at $28,000. Bleakley Financial Group LLC purchased a new stake in shares of Quantum-Si in the first quarter valued at $28,000. Commonwealth Equity Services LLC purchased a new stake in shares of Quantum-Si in the third quarter valued at $28,000. Pathstone Family Office LLC bought a new stake in shares of Quantum-Si in the 3rd quarter worth about $43,000. Finally, State Board of Administration of Florida Retirement System purchased a new position in shares of Quantum-Si during the 3rd quarter worth about $59,000. 39.90% of the stock is currently owned by institutional investors.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.